![](https://scdn.x-mol.com/css/images/icon-new-link.png)
样式: 排序: IF: - GO 导出 标记为已读
-
Reply Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-21 Olafur S. Palsson, B. Joseph Elmunzer
-
Continuous Risk Score Predicts Waitlist and Post-transplant Outcomes in Hepatocellular Carcinoma Despite Exception Changes Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-20 Miho Akabane, John C. McVey, Daniel J. Firl, Allison J. Kwong, Marc L. Melcher, W. Ray Kim, Kazunari Sasaki
Continuous risk-stratification of candidates and urgency-based prioritization have been utilized for liver transplantation (LT) in patients with non-hepatocellular carcinoma (HCC) in the United States. Instead, for patients with HCC, a dichotomous criterion with exception points is still used. This study evaluated the utility of the hazard associated with LT for HCC (HALT-HCC), an oncological continuous
-
Fecal Microbiota Transplantation for Sleep Disturbance in Postacute COVID-19 Syndrome Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-20 Raphaela I. Lau, Qi Su, Jessica Y.L. Ching, Rashid N. Lui, Ting Ting Chan, Marc T.L. Wong, Louis H.S. Lau, Yun Kwok Wing, Rachel N.Y. Chan, Hanson Y.H. Kwok, Agnes H.Y. Ho, Yee Kit Tse, Chun Pan Cheung, Moses K.T. Li, Wan Ying Siu, Chengyu Liu, Wenqi Lu, Yun Wang, Emily O.L. Chiu, Pui Kuan Cheong, Francis K.L. Chan, Siew C. Ng
Postacute COVID-19 syndrome (PACS) is associated with sleep disturbance, but treatment options are limited. The etiology of PACS may be secondary to alterations in the gut microbiome. Here, we report the efficacy of fecal microbiota transplantation (FMT) in alleviating post-COVID insomnia symptoms in a nonrandomized, open-label prospective interventional study. Between September 22, 2022, and May 22
-
Trends in Consolidation of Gastroenterology Practices Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-20 Daniel Marino, Mouhand Mohamed, Michelle Kwon, Nhu Dang, Samir A. Shah, Scott Fraser
-
Preoperative Hepatology and Primary Care Visits Improve Postoperative Outcomes in Patients with Cirrhosis Undergoing Surgery Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-19 Bachir Ghandour, Elliot B. Tapper, David E. Kaplan, Marina Serper, Nadim Mahmud
Cirrhosis patients are at increased risk for postoperative complications. It remains unclear whether preoperative nonsurgical clinician visits improve postoperative outcomes. We assessed the impact of preoperative primary care physician (PCP) and/or gastroenterologist/hepatologist (GI/Hep) visits on postoperative mortality in cirrhosis patients undergoing surgery and explored differences in medication
-
-
Revisiting Meta-analyses of Placebo Response in Drug Trials for Irritable Bowel Syndrome: A Call to Disclose Excipients Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-18 Jonathan A. Busam, Ali Rezaie, Mark Pimentel
-
Reply Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-18 Jayanta Samanta, Janhvi Dhar, Antonio Facciorusso
-
Fishbone Penetration Causing Liver Abscess Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-18 Jiakun Duan, Haibin Shi, Zhou Zhou
-
Not So Nutty for Coconut Water Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-18 William Shanahan, Eoin Slattery
-
Sequential SAFE Score and Transient Elastography in Detecting of Significant Fibrosis in Asian Patients with MASLD Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-14 Apichat Kaewdech, Pimsiri Sripongpun, Sombat Treeprasertsuk, Phunchai Charatcharoenwitthaya, Wah Kheong Chan, The GO ASIA Study Group, Naichaya Chamroonkul, Cheng Han Ng, Mark Dhinesh Muthiah, Yock Young Dan, W. Ray Kim
-
The Revised Kyoto Criteria and Risk of Malignancy Among Patients With Intraductal Papillary Mucinous Neoplasms Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-14 Tsuyoshi Hamada, Hiroki Oyama, Shuichi Tange, Ryunosuke Hakuta, Kazunaga Ishigaki, Sachiko Kanai, Yoshikuni Kawaguchi, Kensaku Noguchi, Tomotaka Saito, Tatsuya Sato, Tatsunori Suzuki, Naminatsu Takahara, Mariko Tanaka, Kiyoshi Hasegawa, Tetsuo Ushiku, Yousuke Nakai, Mitsuhiro Fujishiro
The revised Kyoto guidelines have a new catalog of high-risk stigmata and worrisome features for the risk stratification of intraductal papillary mucinous neoplasms (IPMNs). We aimed to validate the stratification system in terms of short- and long-term risks of pancreatic carcinoma. We included 3336 patients diagnosed with IPMNs in 2000–2021 and examined short-term (≤6 months) and long-term risks
-
Ustekinumab and Vedolizumab Safety and Clearance in Pregnancy with Inflammatory Bowel Disease: Stop the Disease, not the Drug! Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-13 Joana Torres, Uma Mahadevan
-
Role of Sex, Anxiety, and Resilience in the Association between Adverse Childhood Experiences and Irritable Bowel Syndrome Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-13 Anna H. Lee, Swapna Mahurkar-Joshi, Bruce Naliboff, Arpana Gupta, Jennifer Labus, Kirsten Tillisch, Emeran Mayer, Lin Chang
-
Stopping Nucleos(t)ide Analogues in Chronic Hepatitis B Using HBsAg Thresholds: A Meta-Analysis and Meta-Regression Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Seng Gee Lim, Ada Ee Der Teo, Edwin Shih-Yen Chan, Wah Wah Phyo, David Hsing Yu Chen, Carol Anne Hargreaves
Recommendations for stopping nucleoside analogue (NA) therapy in hepatitis B e antigen–negative chronic hepatitis B (CHB) are unclear. End-of-treatment quantitative hepatitis B serum antigen (EOTqHBsAg) thresholds <100 IU/mL or <1000 IU/mL have been proposed as stopping criteria, which we assessed by meta-analysis and meta-regression. We searched PubMed, EMBASE, and conference abstracts for studies
-
AGA Clinical Practice Update on Management of Iron Deficiency Anemia: Expert Review Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Thomas G. DeLoughery, Christian S. Jackson, Cynthia W. Ko, Don C. Rockey
In this Clinical Practice Update (CPU), we will Best Practice Advice (BPA) guidance on the appropriate management of iron deficiency anemia. This expert review was commissioned and approved by the AGA Institute Clinical Practice Updates Committee (CPUC) and the AGA Governing Board to provide timely guidance on a topic of high clinical importance to the AGA membership, and underwent internal peer review
-
Novel Irritable Bowel Syndrome Subgroups are Reproducible in the Global Adult Population Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Christopher J. Black, Lesley A. Houghton, Robert M. West, Shrikant I. Bangdiwala, Olafur S. Palsson, Ami D. Sperber, Alexander C. Ford
-
The Role of Pancreatitis Risk Genes in Endocrine Insufficiency Development After Acute Pancreatitis in Children Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Maisam Abu-El-Haija, Wenying Zhang, Rebekah Karns, Gila Ginzburg, David S. Vitale, Peter Farrell, Alexander Nasr, Sherif Ibrahim, Melena D. Bellin, Tyler Thompson, Vineet Garlapally, Jessica G. Woo, Sohail Z. Husain, Lee A. Denson
Acute pancreatitis (AP) is increasingly recognized as a risk factor for diabetes mellitus (DM). We aimed to study the association of pancreatitis genes with pancreatic endocrine insufficiency (pre-DM and DM) development post-AP in children. This was an observational cohort study that enrolled subjects ≤21 years with their first episode of AP and followed them for 12 months for the development of pancreatic
-
Plummer-Vinson Syndrome: Classic Triad of Iron Deficiency Anemia, Dysphagia, and Esophageal Webs Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Yakov Mamzhi, Richard Sukov, Amrit K. Kamboj
-
Perianal Fistulizing Crohn’s Disease–Associated Anorectal and Fistula Cancers: Systematic Review and Expert Consensus Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-12 Serre-Yu Wong, Cathy Rowan, Elvira Diaz Brockmans, Cindy C.Y. Law, Elisabeth Giselbrecht, Celina Ang, Sergey Khaitov, David Sachar, Alexandros D. Polydorides, Leon Shin-han Winata, Bram Verstockt, Antonino Spinelli, David T. Rubin, Parakkal Deepak, Dermot P.B. McGovern, Benjamin D. McDonald, Phillip Lung, Lilli Lundby, Amy L. Lightner, Stefan D. Holubar, Luke Hanna, Carla Hamarth, Jeroen Geldof, Anders
Perianal fistulizing Crohn’s disease (PFCD)-associated anorectal and fistula cancers are rare but often devastating diagnoses. However, given the low incidence and consequent lack of data and clinical trials in the field, there is little to no guidance on screening and management of these cancers. To inform clinical practice, we developed consensus guidelines on PFCD-associated anorectal and fistula
-
Real-world Effectiveness of Fecal Microbiota Transplantation for First or Second Clostridioides difficile Infection Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-11 Sara Ellegaard Paaske, Simon Mark Dahl Baumwall, Tone Rubak, Frederik Hyllested Birn, Nina Rågård, Jens Kelsen, Mette Mejlby Hansen, Lise Svenningsen, Anne Lund Krarup, Christa Marie Culmbach Fernis, Anders Neumann, Anders Bergh Lødrup, Henning Glerup, Lars Vinter-Jensen, Morten Helms, Lise Tornvig Erikstrup, Anne Karmisholt Grosen, Susan Mikkelsen, Christian Erikstrup, Jens Frederik Dahlerup, Christian
-
Screening Endoscopy in Patients With Advanced Chronic Liver Disease – Is It All About Varices? Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-11 Rui Morais, Rodrigo Liberal, Guilherme Macedo
-
Screening for Social Determinants of Health in Underserved Populations to Promote Better Outcomes in ALD and MASLD Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-11 Michael Sun, Aivi A. Rahman, Vincent J.H. Yao
-
Age Affects Esophageal Secondary Peristalsis More Than Primary as Assessed by FLIP Panometry and High-resolution Manometry Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-10 Daniel Arndorfer, John E. Pandolfino, Peter J. Kahrilas, Dustin A. Carlson
Age-related changes in esophageal function involve increased rates of dysmotility with advancing age (sometimes described as presbyesophagus). Specifically, advanced age has been associated with increased lower esophageal sphincter (LES) pressure and decreased peristaltic vigor. However, the mechanisms underlying these changes, including the relative relationship of primary peristalsis and secondary
-
Prevalence of Steatotic Liver Disease Subtypes and Association With Metabolic Risk Factors in the Framingham Heart Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-09 Natalie Sun, Brenton Prescott, Jiantao Ma, Arpan Mohanty, Michelle T. Long, Maura E. Walker
-
Abdominal Pain, Jaundice, and Photosensitivity Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Wei Jiang, Xiaoling Wang, Taoyou Zhou
-
An Unusual Cause of Hilar Biliary Obstruction Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Hayden Rotramel, Mahmoud Y. Madi, Wissam Kiwan
-
Very Low-density Lymphadenopathy in Whipple Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Rangesh Modi, Lindsay Yassan, Dejan Micic
-
Incidental Mixed Adenoma-Neuroendocrine Neoplasm (MiNEN) of Duodenum and Whipple Disease Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Swachi Jain, Erin Toto, Rashmi Tondon
-
Reply Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Junya Arai, Yoku Hayakawa, Mitsuhiro Fujishiro
-
Aspirin-Related Chemoprevention of GI Cancers and Bleeding-Related Mortality in Helicobacter Pylori–Eradicated Patients Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Yi Bao, Yanming Xu
-
Ensuring Consistency and Accuracy in Evaluating ChatGPT-4 for Clinical Recommendations Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-08 Lingxuan Zhu, Weiming Mou, Peng Luo
-
-
Provider Specialization in Inflammatory Bowel Diseases: Quality of Care and Outcomes Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-06-04 James D. Lewis, Colleen M. Brensinger, Lauren E. Parlett, Andres Hurtado-Lorenzo, Michael D. Kappelman
-
Enduring Clinical Remission in Refractory Celiac Disease Type II with Tofacitinib: An Open-Label Clinical Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-29 Tessa Dieckman, Michael Schumann, Hanneke Beaumont, Hetty J. Bontkes, Frits Koning, Gerd Bouma, RCDII Tofacitinib Consortium, Valerie Byrnes, Jane McCarthy, Andra Neefjes-Borst, Christoph Loddenkemper, Marlous op de Weegh, K.E.A. Lundin
-
Hereditary Angioedema: A Rare Cause of Acute Pancreatitis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-29 Qing Lu, Jia-Huan Liu, Jin-Lin Yang
-
Combination Treatment in MASLD: The Next Frontier Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-28 Emmanuel A. Tsochatzis, Mazen Noureddin
-
Performance Improvement and Artificial Intelligence (AI) Emerge to Bridge the Gap for Exceptional Gastroenterology Physician Onboarding Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-27 John D. Rudnick Jr., Michael J. Back, James A. Turner Jr., Michelle L. Vezina
-
Rigorous Donor Selection for Fecal Microbiota Transplantation in Active Ulcerative Colitis: Key Lessons From a Randomized Controlled Trial Halted for Futility Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-23 Clara Caenepeel, Sara Deleu, Jorge Francisco Vazquez Castellanos, Kaline Arnauts, Sara Braekeleire, Kathleen Machiels, Filip Baert, Fazia Mana, Lieven Pouillon, Pieter Hindryckx, Triana Lobaton, Edouard Louis, Denis Franchimont, Bram Verstockt, Marc Ferrante, João Sabino, Sara Vieira-Silva, Gwen Falony, Jeroen Raes, Séverine Vermeire
-
Development and Validation of a Scoring System to Predict Response to Obeticholic Acid in Primary Biliary Cholangitis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-22 Antonio De Vincentis, Javier Ampuero, Francesca Terracciani, Daphne D’Amato, Alessio Gerussi, Laura Cristoferi, Nora Cazzagon, Emanuela Bonaiuto, Annarosa Floreani, Vincenza Calvaruso, Luca Cadamuro, Elisabetta Degasperi, Anna Morgando, Ester Vanni, Ana Lleo, Francesca Colapietro, Domenico Alvaro, Antonino Castellaneta, Sara Labanca, Mauro Viganò, Marco Distefano, Valeria Pace Palitti, Chiara Ricci
-
-
Sex-Related Differences in the Phenotype and Course of Inflammatory Bowel Disease: SEXEII Study of ENEIDA Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-22 Carla J. Gargallo-Puyuelo, Elena Ricart, Eva Iglesias, Ruth de Francisco, Javier P. Gisbert, Carlos Taxonera, Miriam Mañosa, Mariam Aguas Peris, Eva María Navarrete-Muñoz, Ana Sanahuja, Jordi Guardiola, Francisco Mesonero, Montserrat Rivero Tirado, Jesús Barrio, Isabel Vera Mendoza, Luisa de Castro Parga, Esther García-Planella, Xavier Calvet, María Dolores Martín Arranz, Santiago García, Beatriz Sicilia
-
Underwater Endoscopic Mucosal Resection Vs Conventional Endoscopic Mucosal Resection for Superficial Nonampullary Duodenal Epithelial Tumors in the Western Setting Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-22 Rui Morais, José Amorim, Renato Medas, Bernardo Sousa-Pinto, João Santos-Antunes, Romain Legros, Jérémie Albouys, Frédéric Moll, Margarida Marques, Filipe Vilas-Boas, Eduardo Rodrigues-Pinto, Irene Gullo, Fátima Carneiro, Elisa Gravito Soares, Pedro Amaro, Pedro Mesquita, Jaime Rodrigues, Gianluca Andrisani, Sandro Sferrazza, Sara Archer, Ricardo Kuttner-Magalhães, Francisco Manzano, Enrique Rodríguez
-
Cost Effectiveness of the Baveno VI Criteria Compared With Endoscopy for High-Risk Varices in Patients With Child-Pugh A Cirrhosis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-21 Elena Pizzo, Tuba Saygın Avşar, Juan G. Abraldes, Joan Genesca, Emmanuel A. Tsochatzis
-
Human Endoscopic Ultrasonography Using Linear Array Scope for Pancreatic Diseases Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-21 Matthew J. DiMagno, Eugene P. DiMagno
-
Lead Time and Immortal Time Biases Impact the Calculation of Post-colonoscopy Colorectal Cancer Survival Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-21 James H.-E. Kang, Christopher D. Jensen, Sophie A. Merchant, Jeffrey K. Lee
The World Endoscopy Organization (WEO) standardized the reporting of post-colonoscopy colorectal cancers (PCCRCs), which account for 7% to 10% of colorectal cancers (CRCs). PCCRCs are diagnosed 6 to 36 months after a false negative colonoscopy. Detected CRCs (dCRCs) are diagnosed ≤6 months after an index true positive colonoscopy. PCCRC prognosis is unclear, with outcomes reported as comparable, superior
-
MetALD: The Outcome of Living Under the Shadow of Alcohol for 4 Decades Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-21 Nahum Méndez-Sánchez, Mariana M. Ramírez-Mejía
-
Risk of Kidney Failure in Patients With Inflammatory Bowel Disease Undergoing Colectomy: A Nationwide Cohort Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-20 Yuanhang Yang, Jonas F. Ludvigsson, Anders Forss, Anne-Laure Faucon, Adam S. Faye, Ola Olén, Arvid Sjölander, Juan J. Carrero
Inflammatory bowel disease (IBD) is frequently accompanied by kidney complications. Potential triggers or subpopulations at high-risk of kidney problems are not well-elucidated. We hypothesized that surgical interventions, specifically colectomy, might in part explain this risk. This study was a nationwide Swedish cohort study comprising 82,051 individuals with biopsy-proven IBD diagnosed during 1965
-
Comparison of Los Angeles Grades of Erosive Esophagitis Scored by Local Investigators vs Central Adjudicators in a Clinical Trial Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-20 Stuart J. Spechler, Loren Laine, Kenneth R. Devault, Azmi Nabulsi, Barbara Hunt, Philip Katz
-
A Rare Cause of Acute Pancreatitis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-19 Saleh Alghaythi, Badr Al-Bawardy, Aymen Almuhaidb
-
Antibiotic Use and the Risk of Pouchitis After Ileal Pouch-Anal Anastomosis for Ulcerative Colitis Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-18 Cong Dai, Yu-Hong Huang, Min Jiang
-
Safety of Immunosuppression in a Prospective Cohort of Inflammatory Bowel Disease Patients With a HIstoRy of CancEr: SAPPHIRE Registry Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-18 Steven H. Itzkowitz, Yue Jiang, Cristina Villagra, Jean-Frederic Colombel, Keith Sultan, Dana J. Lukin, David M. Faleck, Ellen Scherl, Shannon Chang, LeaAnn Chen, Seymour Katz, Joann Kwah, Arun Swaminath, Francesca Petralia, Virginia Sharpless, David Sachar, Lina Jandorf, Jordan E. Axelrad, New York Crohn’s and Colitis Organization
-
Small Transjugular Intrahepatic Portosystemic Shunt Plus Variceal Embolization for Gastric Varices: A Multicenter Cohort Study Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-16 Yifu Xia, Jun Tie, Guangchuan Wang, Yuzheng Zhuge, Hao Wu, Xiaoli Zhu, Hui Xue, Jiao Xu, Feng Zhang, Lianhui Zhao, Guangjun Huang, Mingyan Zhang, Bo Wei, Peijie Li, Ze Wang, Wei Wu, Chao Chen, Shifeng Yang, Yicheng Han, Chengwei Tang, Chunqing Zhang
-
Environmental Factors Associated with Risk of Crohn’s Disease Development in the Crohn’s and Colitis Canada - Genetic, Environmental, Microbial Project Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-16 Mingyue Xue, Haim Leibovitzh, Shao Jingcheng, Anna Neustaeter, Mei Dong, Wei Xu, Osvaldo Espin-Garcia, Anne M. Griffiths, A. Hillary Steinhart, Dan Turner, Hien Q. Huynh, Levinus A. Dieleman, Remo Panaccione, Guy Aumais, Brian Bressler, Alain Bitton, Sanjay Murthy, John K. Marshall, Jeffrey S. Hyams, Anthony Otley, Charles N. Bernstein, Paul Moayyedi, Wael El-Matary, Alexander Fich, Lee A. Denson,
To date, it is unclear how environmental factors influence Crohn’s disease (CD) risk and how they interact with biological processes. This study investigates the association between environmental exposures and CD risk and evaluates their association with pre-disease biomarkers. We studied 4289 healthy first-degree relatives (FDRs) of patients with CD from the Crohn’s and Colitis Canada - Genetic, Environmental
-
Nationally Automated Colonoscopy Performance Feedback Increases Polyp Detection: The NED APRIQOT Randomized Controlled Trial Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-16 Jamie Catlow, Linda Sharp, Janelle Wagnild, Liya Lu, Rashmi Bhardwaj-Gosling, Emmanuel Ogundimu, Adetayo Kasim, Matthew Brookes, Thomas Lee, Stephen McCarthy, Joanne Gray, Falko Sniehotta, Roland Valori, Claire Westwood, Richard McNally, Josephine Ruwende, Simon Sinclair, Jill Deane, NED APRIQOT Trialists Group, Matt Rutter
-
Glucagon-Like Peptide-1 Receptor Agonists Do Not Increase Aspiration During Upper Endoscopy in Patients With Diabetes Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-15 Trevor S. Barlowe, Chelsea Anderson, Robert S. Sandler, Disha Subramaniam, Alicia Muratore, John B. Buse, Lindsey N. Gouker, Rajiv T. Majithia, Nicholas J. Shaheen, Til Stürmer, Michael K. Dougherty
Glucagon-like peptide-1–receptor agonists (GLP1-RAs) have been associated with greater retention of gastric contents, however, there is minimal controlled, population-based data evaluating the potential adverse effects of GLP1-RA in the periprocedural setting. We aimed to determine if there is increased risk of aspiration and aspiration-related complications after upper endoscopy in patients using
-
Recent Advancement and Future Perspective of Per Oral Endoscopic Myotomy Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-15 Mohan Ramchandani, Zaheer Nabi, Pradev Inavolu, D. Nageshwar Reddy
Per oral endoscopic myotomy (POEM) has emerged as a preferred approach for the treatment of idiopathic achalasia and various esophageal motility disorders, offering a minimally invasive alternative to traditional laparoscopic Heller’s myotomy. Over the past decade, POEM has solidified its status as the primary therapeutic choice in these conditions through constant improvements. Its evolution has been
-
Association of Ultra-processed Food and Unprocessed or Minimally Processed Food Consumption With Bowel Habits Among U.S. Adults Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-15 Chun-Han Lo, Longgang Zhao, Euridice Martinez Steele, Chun-Wei Pan, Jeffrey K. Lee, Xuehong Zhang, Harminder Singh, N. Jewel Samadder
-
PII: S1542-3565(24)00444-0 Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-15 Robert S. Rahimi, Don C. Rockey, Jasmohan S. Bajaj
-
Vonoprazan is Efficacious for Treatment of Heartburn in Non-erosive Reflux Disease: A Randomized Trial Clin. Gastroenterol. Hepatol. (IF 11.6) Pub Date : 2024-05-14 Loren Laine, Stuart Spechler, Rena Yadlapati, Felice Schnoll-Sussman, Neila Smith, Eckhard Leifke, Tom Harris, Barbara Hunt, Ronnie Fass, Philip Katz